Skip to main content

Table 3 Dyslipidemia prevalence in the sample (cases)

From: Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of mexican population: a preliminary report

Variable TAG* (mg/dL) TC* (mg/dL) HDL-C* (mg/dL) LDL-C* (mg/dL)
  <200 >200 <(200/240) >(200/240) <35 >35 <130 >130
Initial (n = 36) 21 15 26/33 10/3 10 26 27 9
Final (n = 36) 28 8 31/36 5/0 8 28 33 3
  1. * p < 0.05 initial vs. final, chi-squared test